Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121251
Status:
COMPLETED
Last Update Posted:
2021-04-06
First Post:
2005-07-19
Brief Title:
Sorafenib Gemcitabine and Capecitabine in Treating Patients With Unresectable andor Metastatic Kidney Cancer
Sponsor:
Organization:
National Cancer Institute NCI